Alogliptin and Pioglitazone

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 45802-402
  • Package NDC 45802-402-65
  • Application number NDA022426
  • SPL ID 11c471e0-6c64-4f13-b6ed-d2c80bc89f20
  • SPL set ID 642b1e90-701e-42f2-bac6-a4918738e2c9
  • UNII JQT35NPK6C
  • UNII EEN99869SC
  • RxCUI 1368410
  • RxCUI 1368424
  • RxCUI 1368431
  • RxCUI 1368438

What the source publishes

Labeler
Padagis Israel Pharmaceuticals Ltd
Active ingredients
Alogliptin Benzoate and Pioglitazone hydrochloride
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA AUTHORIZED GENERIC
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:45802-402_11c471e0-6c64-4f13-b6ed-d2c80bc89f20
{
  "name": "Alogliptin and Pioglitazone",
  "splId": "11c471e0-6c64-4f13-b6ed-d2c80bc89f20",
  "labels": [
    {
      "setId": "642b1e90-701e-42f2-bac6-a4918738e2c9",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=642b1e90-701e-42f2-bac6-a4918738e2c9",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=642b1e90-701e-42f2-bac6-a4918738e2c9"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Padagis Israel Pharmaceuticals Ltd",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (45802-402-65)",
      "package_ndc": "45802-402-65",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20160408"
    }
  ],
  "productId": "45802-402_11c471e0-6c64-4f13-b6ed-d2c80bc89f20",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "45802-402",
  "deaSchedule": null,
  "genericName": "Alogliptin Benzoate and Pioglitazone hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ALOGLIPTIN BENZOATE",
      "strength": "25 mg/1"
    },
    {
      "name": "PIOGLITAZONE HYDROCHLORIDE",
      "strength": "30 mg/1"
    }
  ],
  "applicationNumber": "NDA022426",
  "marketingCategory": "NDA AUTHORIZED GENERIC",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160408",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0345802260659",
      "0345802402653",
      "0345802351654",
      "0345802499653"
    ],
    "unii": [
      "JQT35NPK6C",
      "EEN99869SC"
    ],
    "rxcui": [
      "1368410",
      "1368424",
      "1368431",
      "1368438"
    ],
    "spl_set_id": [
      "642b1e90-701e-42f2-bac6-a4918738e2c9"
    ],
    "manufacturer_name": [
      "Padagis Israel Pharmaceuticals Ltd"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:45802-402_11c471e0-6c64-4f13-b6ed-d2c80bc89f20"